Salarius Pharmaceuticals (SLRX) Short Interest Ratio & Short Volume $4.28 -0.08 (-1.72%) As of 01:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Salarius Pharmaceuticals Short Interest DataSalarius Pharmaceuticals (SLRX) has a short interest of 54,200 shares, representing 10.65% of the float (the number of shares available for trading by the public). This marks a -56.22% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 176,568 shares to cover all short positions.Current Short Interest54,200 sharesPrevious Short Interest123,800 sharesChange Vs. Previous Month-56.22%Dollar Volume Sold Short$295.39 thousandShort Interest Ratio0.2 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares510,000 sharesFloat Size508,900 sharesShort Percent of Float10.65%Today's Trading Volume179,659 sharesAverage Trading Volume176,568 sharesToday's Volume Vs. Average102% Short Selling Salarius Pharmaceuticals? Sign up to receive the latest short interest report for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLRX Short Interest Over TimeSLRX Days to Cover Over TimeSLRX Percentage of Float Shorted Over Time Salarius Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/202554,200 shares $295.39 thousand -56.2%10.7%0.2 $5.45 8/31/2025123,800 shares $713.09 thousand +56.5%24.5%0.5 $5.76 8/15/202579,100 shares $547.93 thousand -90.2%15.6%0.4 $6.93 7/31/2025803,600 shares $481.60 thousand +18.4%10.6%0.3 $0.60 7/15/2025678,500 shares $460.70 thousand -3.9%32.2%0.6 $0.68 6/30/2025705,800 shares $632.33 thousand +2,147.8%33.5%0.6 $0.90 6/15/202531,400 shares $20.64 thousand -34.6%1.5%0 $0.66 5/31/202548,000 shares $37.44 thousand -8.9%2.3%0.2 $0.78 5/15/202552,700 shares $44.78 thousand -37.4%2.5%0.2 $0.85 4/30/202584,200 shares $59.78 thousand -25.4%4.1%0.3 $0.71 Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 4/15/2025112,900 shares $81.29 thousand -18.3%5.4%0.4 $0.72 3/31/2025138,200 shares $104.20 thousand +242.1%8.1%0.1 $0.75 3/15/202540,400 shares $39.19 thousand -52.9%2.4%0 $0.97 2/28/202585,700 shares $92.56 thousand +724.0%5.5%0 $1.08 2/15/202510,400 shares $16.85 thousand -46.1%0.7%0 $1.62 1/31/202519,300 shares $43.23 thousand -93.8%1.3%0 $2.24 1/15/2025311,700 shares $785.48 thousand +902.3%20.2%0.2 $2.52 12/31/202431,100 shares $57.22 thousand +18.3%2.2%0.1 $1.84 12/15/202426,300 shares $38.66 thousand -27.8%1.9%0.1 $1.47 11/30/202436,400 shares $52.05 thousand -33.8%2.6%0.1 $1.43 11/15/202455,000 shares $73.70 thousand -15.4%3.9%0.2 $1.34 10/31/202465,000 shares $104.65 thousand +4,233.3%4.6%0.2 $1.61 10/15/20241,500 shares $2.28 thousand -90.0%0.1%0 $1.52 9/30/202415,000 shares $21.60 thousand +59.6%1.1%0 $1.44 9/15/20249,400 shares $14.66 thousand -38.6%0.7%0 $1.56 8/31/202415,300 shares $25.40 thousand -64.0%1.1%0 $1.66 8/15/202442,500 shares $85.43 thousand -50.8%3.2%0 $2.01 7/31/202486,300 shares $220.93 thousand +44.1%15.4%0 $2.56 7/15/202459,900 shares $106.62 thousand +215.3%10.7%0 $1.78 6/30/202419,000 shares $45.22 thousand +375.0%27.1%0.9 $2.38 6/15/20244,000 shares $13.53 thousand -85.4%5.7%0.2 $3.38 5/31/202427,300 shares $12.65 thousand -18.5%0.6%0.2 $0.46 5/15/202433,500 shares $15.34 thousand -54.5%0.8%0.3 $0.46 4/30/202473,600 shares $36.73 thousand -36.3%1.7%0.6 $0.50 4/15/2024115,600 shares $57.80 thousand -57.0%2.6%1 $0.50 3/31/2024268,900 shares $142.14 thousand +1,767.4%6.7%2.4 $0.53 3/15/202414,400 shares $9.36 thousand -20.0%0.4%0.1 $0.65 2/29/202418,000 shares $12.06 thousand +227.3%0.5%0.6 $0.67 2/15/20245,500 shares $3.25 thousand -33.7%0.2%0.2 $0.59 1/31/20248,300 shares $4.56 thousand +36.1%0.2%0.2 $0.55 1/15/20246,100 shares $3.72 thousand -37.1%0.2%0.2 $0.61 12/31/20239,700 shares $6.31 thousand +38.6%0.3%0.3 $0.65 12/15/20237,000 shares $4.52 thousand -71.9%0.2%0.1 $0.65 11/30/202324,900 shares $17.68 thousand -56.0%0.7%0.4 $0.71 11/15/202356,600 shares $40.75 thousand -22.7%1.6%1.1 $0.72 10/31/202373,200 shares $61.33 thousand +136.9%2.3%1.2 $0.84 10/15/202330,900 shares $21.32 thousand +62.6%0.9%0.5 $0.69 9/30/202319,000 shares $12.50 thousand -6.4%0.6%0.3 $0.66 9/15/202320,300 shares $17.40 thousand -26.5%0.6%0.4 $0.86 8/31/202327,600 shares $24.29 thousand +162.9%0.8%0.5 $0.88 8/15/202310,500 shares $7.49 thousand +54.4%0.3%0.2 $0.71 7/31/20236,800 shares $6.25 thousand -60.9%0.2%0.1 $0.92 7/15/202317,400 shares $19.31 thousand -44.8%0.6%0.2 $1.11 6/30/202331,500 shares $46.94 thousand -41.2%1.0%0.3 $1.49 6/15/202353,600 shares $85.22 thousand +9.6%1.7%0.5 $1.59 5/31/202348,900 shares $68.95 thousand -48.4%2.1%0.5 $1.41 5/15/202394,700 shares $136.37 thousand -16.1%4.2%1 $1.44 4/30/2023112,800 shares $200.78 thousand -11.9%5.4%1.3 $1.78 4/15/2023128,000 shares $220.16 thousand +6.1%6.1%2.5 $1.72 3/31/2023120,700 shares $230.54 thousand -4.2%5.8%0.8 $1.91 3/15/2023126,000 shares $255.78 thousand -4.0%6.6%0.7 $2.03 2/28/2023131,300 shares $279.67 thousand +16.7%6.8%0.7 $2.13 2/15/2023112,500 shares $252.00 thousand +11.3%5.9%0.6 $2.24 1/31/2023101,100 shares $260.84 thousand +37.7%5.2%0.6 $2.58 1/15/202373,400 shares $194.51 thousand +272.6%3.8%0.4 $2.65 12/30/202219,700 shares $30.14 thousand -46.6%1.0%0.3 $1.53 12/15/202236,900 shares $55.72 thousand +93.2%1.9%0.8 $1.51 11/30/202219,100 shares $36.86 thousand -12.0%1.0%0.4 $1.93 11/15/202221,700 shares $46.66 thousand +100.9%1.1%0.5 $2.15 10/31/202210,800 shares $21.92 thousand -31.2%0.5%0.3 $2.03 10/15/202215,700 shares $71.04 thousand -95.8%0.8%0.4 $4.53 9/30/2022371,000 shares $72.35 thousand -8.4%N/A0.9 $0.20 9/15/2022405,000 shares $95.90 thousand +9.6%N/A0.8 $0.24 8/31/2022369,500 shares $74.27 thousand -16.3%N/A0.7 $0.20 8/15/2022441,600 shares $99.36 thousand +257.3%N/A0.7 $0.23 7/31/2022123,600 shares $23.51 thousand +7.3%N/A0.1 $0.19 7/15/2022115,200 shares $21.88 thousand -33.8%N/A0.1 $0.19 6/30/2022174,100 shares $36.56 thousand -54.6%N/A0.1 $0.21 6/15/2022383,300 shares $77.73 thousand -9.8%N/A0.3 $0.20 5/31/2022425,000 shares $76.63 thousand -3.8%N/A0.4 $0.18 5/15/2022441,800 shares $83.01 thousand -26.6%N/A0.4 $0.19 4/30/2022602,200 shares $121.64 thousand +31.4%N/A1.1 $0.20 4/15/2022458,300 shares $163.66 thousand -14.7%N/A1.1 $0.36 3/31/2022537,100 shares $213.82 thousand +11.7%N/A1.3 $0.40 3/15/2022480,900 shares $165.43 thousand -23.8%N/A1 $0.34 2/28/2022630,900 shares $252.42 thousand +0.4%N/A1.8 $0.40 2/15/2022628,200 shares $285.83 thousand -3.7%N/A1.7 $0.46 1/31/2022652,400 shares $293.58 thousand -2.0%4.5%1.5 $0.45 1/15/2022665,600 shares $312.83 thousand +4.2%4.6%1.4 $0.47 12/31/2021638,500 shares $316.44 thousand -7.3%4.4%1.3 $0.50 12/15/2021688,600 shares $365.85 thousand -35.0%4.7%1.4 $0.53 11/30/20211,060,000 shares $689 thousand +1.0%7.3%1.5 $0.65 11/15/20211,050,000 shares $796.95 thousand +7.5%7.2%1.1 $0.76 10/29/2021976,600 shares $808.33 thousand -0.2%6.7%0.8 $0.83 10/15/2021978,900 shares $886.00 thousand -24.1%6.7%0.8 $0.91 9/30/20211,290,000 shares $1.32 million -4.4%8.9%1 $1.02 9/15/20211,350,000 shares $1.39 million -2.9%9.3%1 $1.03 8/31/20211,390,000 shares $1.45 million +9.5%9.6%1 $1.04 8/13/20211,270,000 shares $1.17 million -8.0%8.8%0.7 $0.92 7/30/20211,380,000 shares $1.12 million -9.2%9.5%0.8 $0.81 7/15/20211,520,000 shares $1.38 million -19.2%10.5%0.9 $0.91 6/30/20211,880,000 shares $1.99 million +0.5%13.0%1.1 $1.06 6/15/20211,870,000 shares $2.24 million +14.7%12.9%1.1 $1.20 5/28/20211,630,000 shares $2.09 million -2.4%11.3%1 $1.28 5/14/20211,670,000 shares $2.04 million +29.5%N/A1.3 $1.22 4/30/20211,290,000 shares $1.72 million -5.8%N/A0.6 $1.33 4/15/20211,370,000 shares $1.78 million -12.7%N/A0.6 $1.30 3/31/20211,570,000 shares $2.25 million +41.4%N/A0.6 $1.43 3/15/20211,110,000 shares $1.81 million -41.6%N/A0.4 $1.63 2/26/20211,900,000 shares $3.67 million +15.2%N/A0.7 $1.93 2/12/20211,650,000 shares $4.36 million +202.6%N/A0.6 $2.64 1/29/2021545,200 shares $594.27 thousand -11.3%N/A0.3 $1.09 1/15/2021614,300 shares $712.59 thousand +7.3%N/A0.6 $1.16 12/31/2020572,800 shares $510.94 thousand +22.8%N/A0.7 $0.89 12/15/2020466,600 shares $407.30 thousand -2.1%N/A0.8 $0.87 11/30/2020476,400 shares $325.86 thousand -18.6%N/A1.1 $0.68 11/15/2020585,000 shares $427.05 thousand +3.0%N/A3.9 $0.73 10/30/2020568,000 shares $382.43 thousand -11.4%N/A3.6 $0.67 10/15/2020640,800 shares $583.13 thousand -5.2%N/A2.8 $0.91 SLRX Short Interest - Frequently Asked Questions What is Salarius Pharmaceuticals' current short interest? Short interest is the volume of Salarius Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 54,200 shares of SLRX short. 10.65% of Salarius Pharmaceuticals' shares are currently sold short. Learn More on Salarius Pharmaceuticals' current short interest. What is a good short interest percentage for Salarius Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.65% of Salarius Pharmaceuticals' floating shares are currently sold short. Is Salarius Pharmaceuticals' short interest increasing or decreasing? Salarius Pharmaceuticals saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 54,200 shares, a decline of 56.2% from the previous total of 123,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Salarius Pharmaceuticals' float size? Salarius Pharmaceuticals currently has issued a total of 510,000 shares. Some of Salarius Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Salarius Pharmaceuticals currently has a public float of 508,900 shares. How does Salarius Pharmaceuticals' short interest compare to its competitors? 10.65% of Salarius Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Salarius Pharmaceuticals: Portage Biotech Inc. (4.28%), Alzamend Neuro, Inc. (5.01%), Titan Pharmaceuticals, Inc. (3.74%), Mainz Biomed NV (2.25%), BioCardia, Inc. (2.65%), Brainstorm Cell Therapeutics Inc. (2.97%), Novogen Limited (4.82%), Cardio Diagnostics Holdings, Inc. (3.13%), Purple Biotech Ltd. Sponsored ADR (5.78%), Soligenix Inc. (3.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Salarius Pharmaceuticals stock? Short selling SLRX is an investing strategy that aims to generate trading profit from Salarius Pharmaceuticals as its price is falling. SLRX shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Salarius Pharmaceuticals? A short squeeze for Salarius Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLRX, which in turn drives the price of the stock up even further. How often is Salarius Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLRX, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies PRTG Short Interest ALZN Short Interest TTNP Short Interest MYNZ Short Interest BCDA Short Interest BCLI Short Interest KZIA Short Interest CDIO Short Interest PPBT Short Interest SNGX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLRX) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersThe $20 stock that could make silicon chips obsoleteWhen a new chip can run at the speed of light, the game changes. This is the reality of “TF3” — a man-made...The Oxford Club | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
